| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, N-Methyl-D-Aspartate | 38 | 2023 | 259 | 16.210 |
Why?
|
| Neuralgia | 34 | 2023 | 251 | 13.080 |
Why?
|
| Posterior Horn Cells | 47 | 2023 | 125 | 12.040 |
Why?
|
| Spinal Cord | 65 | 2023 | 690 | 11.160 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 35 | 2023 | 125 | 11.090 |
Why?
|
| Rats, Sprague-Dawley | 144 | 2023 | 2063 | 8.220 |
Why?
|
| Sympathetic Nervous System | 30 | 2023 | 159 | 7.740 |
Why?
|
| Rats | 165 | 2023 | 6086 | 7.570 |
Why?
|
| Hypertension | 26 | 2023 | 1503 | 6.550 |
Why?
|
| Neurons, Afferent | 35 | 2022 | 122 | 6.190 |
Why?
|
| Excitatory Postsynaptic Potentials | 45 | 2020 | 245 | 6.180 |
Why?
|
| Neurons | 46 | 2023 | 2287 | 5.930 |
Why?
|
| Sensory Receptor Cells | 16 | 2023 | 141 | 5.590 |
Why?
|
| Synaptic Transmission | 27 | 2021 | 443 | 5.200 |
Why?
|
| Ganglia, Spinal | 32 | 2022 | 237 | 5.150 |
Why?
|
| Hyperalgesia | 25 | 2023 | 238 | 5.060 |
Why?
|
| gamma-Aminobutyric Acid | 29 | 2016 | 269 | 4.920 |
Why?
|
| Glutamic Acid | 25 | 2021 | 309 | 4.580 |
Why?
|
| Receptors, Opioid, mu | 16 | 2022 | 86 | 4.450 |
Why?
|
| Pain | 37 | 2022 | 1658 | 4.390 |
Why?
|
| Synapses | 23 | 2023 | 509 | 4.240 |
Why?
|
| Morphine | 20 | 2023 | 308 | 4.120 |
Why?
|
| Calcium Channels, L-Type | 7 | 2021 | 76 | 4.110 |
Why?
|
| Hypothalamus | 12 | 2023 | 255 | 3.860 |
Why?
|
| Diabetic Neuropathies | 13 | 2019 | 101 | 3.770 |
Why?
|
| TRPV Cation Channels | 14 | 2019 | 76 | 3.640 |
Why?
|
| Analgesics, Opioid | 28 | 2023 | 1371 | 3.420 |
Why?
|
| Receptors, Muscarinic | 18 | 2016 | 69 | 3.320 |
Why?
|
| Receptors, AMPA | 7 | 2022 | 70 | 3.300 |
Why?
|
| Presynaptic Terminals | 14 | 2020 | 114 | 3.290 |
Why?
|
| Animals | 225 | 2023 | 59536 | 3.280 |
Why?
|
| Nitric Oxide | 18 | 2017 | 644 | 2.990 |
Why?
|
| Receptors, Metabotropic Glutamate | 8 | 2020 | 63 | 2.850 |
Why?
|
| Nociceptors | 19 | 2019 | 86 | 2.840 |
Why?
|
| Rats, Inbred WKY | 22 | 2023 | 110 | 2.810 |
Why?
|
| Analgesics | 18 | 2023 | 390 | 2.790 |
Why?
|
| Calcium Channels | 10 | 2019 | 197 | 2.750 |
Why?
|
| Rats, Inbred SHR | 21 | 2023 | 113 | 2.740 |
Why?
|
| Chronic Pain | 6 | 2023 | 238 | 2.620 |
Why?
|
| Receptors, Presynaptic | 8 | 2022 | 27 | 2.600 |
Why?
|
| Nociception | 9 | 2022 | 45 | 2.490 |
Why?
|
| Up-Regulation | 14 | 2022 | 2450 | 2.450 |
Why?
|
| Patch-Clamp Techniques | 34 | 2020 | 388 | 2.390 |
Why?
|
| Protein Kinase C | 8 | 2022 | 396 | 2.380 |
Why?
|
| Neuronal Plasticity | 12 | 2022 | 304 | 2.370 |
Why?
|
| Receptors, GABA-B | 9 | 2010 | 33 | 2.280 |
Why?
|
| Afferent Pathways | 16 | 2009 | 64 | 2.210 |
Why?
|
| Casein Kinase II | 5 | 2014 | 69 | 2.210 |
Why?
|
| Spinal Nerves | 9 | 2017 | 45 | 2.190 |
Why?
|
| Calcineurin Inhibitors | 4 | 2023 | 68 | 2.030 |
Why?
|
| Peripheral Nerve Injuries | 7 | 2018 | 60 | 1.980 |
Why?
|
| Neural Inhibition | 16 | 2010 | 147 | 1.950 |
Why?
|
| Blood Pressure | 20 | 2023 | 1467 | 1.930 |
Why?
|
| Excitatory Amino Acid Antagonists | 17 | 2017 | 151 | 1.900 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 12 | 2022 | 33 | 1.860 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2011 | 224 | 1.830 |
Why?
|
| Male | 180 | 2023 | 123000 | 1.800 |
Why?
|
| Calcium Channels, T-Type | 5 | 2011 | 27 | 1.760 |
Why?
|
| Calcium Channels, N-Type | 5 | 2015 | 39 | 1.690 |
Why?
|
| Inhibitory Postsynaptic Potentials | 9 | 2010 | 48 | 1.680 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2023 | 80 | 1.650 |
Why?
|
| Solute Carrier Family 12, Member 2 | 3 | 2023 | 10 | 1.580 |
Why?
|
| Calcineurin | 6 | 2022 | 128 | 1.570 |
Why?
|
| Angiotensin II | 5 | 2018 | 198 | 1.540 |
Why?
|
| Acute Pain | 3 | 2022 | 42 | 1.530 |
Why?
|
| Receptor, Muscarinic M2 | 9 | 2018 | 24 | 1.530 |
Why?
|
| Membrane Potentials | 16 | 2014 | 424 | 1.510 |
Why?
|
| In Vitro Techniques | 27 | 2014 | 1618 | 1.450 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2020 | 461 | 1.440 |
Why?
|
| Pain Measurement | 19 | 2019 | 953 | 1.420 |
Why?
|
| Pain Threshold | 17 | 2018 | 130 | 1.380 |
Why?
|
| Chlorides | 3 | 2016 | 139 | 1.380 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 7 | 2011 | 23 | 1.270 |
Why?
|
| Glycine | 9 | 2014 | 289 | 1.270 |
Why?
|
| Bradykinin | 16 | 2007 | 79 | 1.250 |
Why?
|
| Diterpenes | 16 | 2021 | 111 | 1.190 |
Why?
|
| Medulla Oblongata | 6 | 2014 | 45 | 1.140 |
Why?
|
| Drug Tolerance | 4 | 2019 | 114 | 1.130 |
Why?
|
| Autonomic Nervous System | 3 | 2013 | 72 | 1.080 |
Why?
|
| Calcium | 10 | 2021 | 1537 | 1.080 |
Why?
|
| 4-Aminopyridine | 5 | 2014 | 41 | 1.080 |
Why?
|
| Dose-Response Relationship, Drug | 31 | 2020 | 4938 | 1.080 |
Why?
|
| Heart | 10 | 2007 | 1223 | 1.070 |
Why?
|
| Long-Term Potentiation | 2 | 2021 | 176 | 1.060 |
Why?
|
| Receptor, Muscarinic M4 | 7 | 2011 | 21 | 1.040 |
Why?
|
| Clonidine | 9 | 2007 | 71 | 1.030 |
Why?
|
| Injections, Spinal | 23 | 2016 | 257 | 1.020 |
Why?
|
| Potassium Channel Blockers | 11 | 2014 | 110 | 1.010 |
Why?
|
| Adrenergic alpha-Agonists | 9 | 2008 | 42 | 1.000 |
Why?
|
| Mice, Knockout | 17 | 2022 | 5710 | 0.990 |
Why?
|
| Ion Channels | 3 | 2020 | 212 | 0.990 |
Why?
|
| Electrophysiology | 18 | 2014 | 333 | 0.970 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 3 | 2021 | 25 | 0.970 |
Why?
|
| DNA Demethylation | 1 | 2023 | 10 | 0.960 |
Why?
|
| Bicuculline | 13 | 2016 | 55 | 0.960 |
Why?
|
| Muscarinic Agonists | 11 | 2010 | 40 | 0.950 |
Why?
|
| Receptor, Cannabinoid, CB1 | 3 | 2020 | 33 | 0.940 |
Why?
|
| Tacrolimus | 4 | 2023 | 335 | 0.930 |
Why?
|
| Drug Interactions | 15 | 2016 | 553 | 0.930 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 5 | 2008 | 16 | 0.920 |
Why?
|
| GABA Antagonists | 13 | 2010 | 53 | 0.910 |
Why?
|
| Plant Lectins | 5 | 2008 | 27 | 0.910 |
Why?
|
| Amitriptyline | 1 | 2023 | 38 | 0.910 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 4 | 2023 | 19 | 0.910 |
Why?
|
| Mice | 32 | 2023 | 34495 | 0.900 |
Why?
|
| Protein Subunits | 4 | 2021 | 274 | 0.900 |
Why?
|
| Acetylcholine | 6 | 2009 | 96 | 0.890 |
Why?
|
| Receptors, Glutamate | 3 | 2017 | 19 | 0.890 |
Why?
|
| Receptors, Cannabinoid | 1 | 2022 | 8 | 0.860 |
Why?
|
| Nociceptive Pain | 2 | 2019 | 8 | 0.850 |
Why?
|
| Streptozocin | 3 | 2019 | 75 | 0.840 |
Why?
|
| Nerve Fibers, Unmyelinated | 4 | 2007 | 15 | 0.840 |
Why?
|
| Homeostasis | 4 | 2016 | 950 | 0.840 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 11 | 2014 | 47 | 0.830 |
Why?
|
| Cannabinoids | 1 | 2022 | 38 | 0.830 |
Why?
|
| Theta Rhythm | 1 | 2021 | 29 | 0.830 |
Why?
|
| Potassium Channels | 2 | 2015 | 162 | 0.820 |
Why?
|
| Adrenergic Fibers | 2 | 2017 | 8 | 0.810 |
Why?
|
| Heart Rate | 7 | 2011 | 737 | 0.800 |
Why?
|
| Receptors, Drug | 4 | 2004 | 48 | 0.790 |
Why?
|
| Myocardial Ischemia | 8 | 2004 | 435 | 0.780 |
Why?
|
| Capsaicin | 8 | 2009 | 47 | 0.780 |
Why?
|
| Analgesia | 4 | 2019 | 94 | 0.780 |
Why?
|
| Protein Transport | 2 | 2021 | 734 | 0.760 |
Why?
|
| Electric Stimulation | 14 | 2014 | 426 | 0.750 |
Why?
|
| Narcotics | 3 | 2006 | 123 | 0.750 |
Why?
|
| Cyclohexanecarboxylic Acids | 5 | 2009 | 42 | 0.740 |
Why?
|
| Gene-Environment Interaction | 1 | 2021 | 166 | 0.740 |
Why?
|
| Muscarine | 4 | 2018 | 16 | 0.740 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2012 | 176 | 0.730 |
Why?
|
| Amines | 5 | 2009 | 85 | 0.730 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2009 | 393 | 0.720 |
Why?
|
| Reflex | 7 | 2004 | 68 | 0.710 |
Why?
|
| Pressoreceptors | 3 | 2009 | 18 | 0.700 |
Why?
|
| TRPA1 Cation Channel | 1 | 2019 | 10 | 0.700 |
Why?
|
| N-Methylaspartate | 2 | 2022 | 50 | 0.700 |
Why?
|
| Action Potentials | 12 | 2014 | 560 | 0.690 |
Why?
|
| Spinal Cord Dorsal Horn | 3 | 2023 | 11 | 0.690 |
Why?
|
| Receptors, GABA-A | 3 | 2008 | 79 | 0.690 |
Why?
|
| Behavior, Animal | 13 | 2020 | 709 | 0.680 |
Why?
|
| Receptors, Opioid, delta | 4 | 2008 | 26 | 0.680 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 6942 | 0.680 |
Why?
|
| Electrophysiological Phenomena | 5 | 2019 | 75 | 0.670 |
Why?
|
| Vasomotor System | 2 | 2010 | 29 | 0.670 |
Why?
|
| Organ Culture Techniques | 6 | 2020 | 241 | 0.660 |
Why?
|
| Ischemia | 9 | 1997 | 391 | 0.660 |
Why?
|
| Disease Models, Animal | 20 | 2018 | 7222 | 0.650 |
Why?
|
| HEK293 Cells | 7 | 2021 | 1489 | 0.650 |
Why?
|
| Spinal Nerve Roots | 4 | 2014 | 65 | 0.650 |
Why?
|
| Physical Stimulation | 10 | 2014 | 112 | 0.640 |
Why?
|
| Norepinephrine | 8 | 2023 | 272 | 0.630 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2010 | 64 | 0.620 |
Why?
|
| Gene Expression | 3 | 2013 | 3570 | 0.620 |
Why?
|
| Neural Pathways | 8 | 2008 | 298 | 0.620 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 103 | 0.610 |
Why?
|
| Hippocampus | 3 | 2020 | 915 | 0.610 |
Why?
|
| Receptors, Nicotinic | 5 | 2001 | 190 | 0.610 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2008 | 39 | 0.600 |
Why?
|
| Receptor, Cannabinoid, CB2 | 5 | 2020 | 16 | 0.590 |
Why?
|
| Kv1.2 Potassium Channel | 2 | 2007 | 16 | 0.590 |
Why?
|
| Gene Silencing | 2 | 2020 | 837 | 0.580 |
Why?
|
| Microinjections | 6 | 2020 | 96 | 0.580 |
Why?
|
| Kv1.1 Potassium Channel | 2 | 2007 | 39 | 0.580 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 2 | 2018 | 32 | 0.570 |
Why?
|
| Casein Kinase I | 2 | 2015 | 23 | 0.570 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 184 | 0.570 |
Why?
|
| Nerve Fibers | 7 | 2009 | 106 | 0.560 |
Why?
|
| Receptors, Opioid | 3 | 2022 | 35 | 0.560 |
Why?
|
| Vestibular Nuclei | 1 | 2016 | 15 | 0.560 |
Why?
|
| Cats | 20 | 2002 | 166 | 0.550 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2017 | 126 | 0.550 |
Why?
|
| Paclitaxel | 3 | 2023 | 1996 | 0.540 |
Why?
|
| Calpain | 2 | 2013 | 64 | 0.540 |
Why?
|
| Symporters | 2 | 2016 | 98 | 0.540 |
Why?
|
| Brain Ischemia | 1 | 2018 | 292 | 0.540 |
Why?
|
| Hot Temperature | 6 | 2017 | 281 | 0.530 |
Why?
|
| Signal Transduction | 8 | 2014 | 11965 | 0.530 |
Why?
|
| Bortezomib | 1 | 2017 | 543 | 0.520 |
Why?
|
| Penicillamine | 4 | 2004 | 22 | 0.520 |
Why?
|
| Connexins | 1 | 2015 | 78 | 0.510 |
Why?
|
| Viscera | 5 | 2001 | 81 | 0.510 |
Why?
|
| Baroreflex | 2 | 2009 | 11 | 0.510 |
Why?
|
| Neostigmine | 5 | 2004 | 17 | 0.510 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 1399 | 0.510 |
Why?
|
| Locus Coeruleus | 3 | 2004 | 33 | 0.510 |
Why?
|
| Adenosine | 4 | 2010 | 289 | 0.500 |
Why?
|
| Sciatic Nerve | 6 | 2021 | 112 | 0.500 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2014 | 13 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 848 | 0.500 |
Why?
|
| Receptor, Muscarinic M3 | 4 | 2009 | 20 | 0.500 |
Why?
|
| Peptides | 7 | 2022 | 1479 | 0.490 |
Why?
|
| Amygdala | 2 | 2005 | 127 | 0.480 |
Why?
|
| Trauma, Nervous System | 1 | 2013 | 10 | 0.470 |
Why?
|
| Calmodulin | 2 | 2014 | 241 | 0.470 |
Why?
|
| src-Family Kinases | 1 | 2016 | 478 | 0.470 |
Why?
|
| Neuromuscular Junction | 2 | 2014 | 90 | 0.470 |
Why?
|
| Down-Regulation | 5 | 2018 | 2074 | 0.470 |
Why?
|
| Cholinergic Agents | 4 | 2016 | 21 | 0.460 |
Why?
|
| Pons | 1 | 2013 | 51 | 0.450 |
Why?
|
| Membrane Proteins | 3 | 2020 | 2819 | 0.450 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2012 | 11 | 0.440 |
Why?
|
| Glutamates | 2 | 2020 | 130 | 0.440 |
Why?
|
| Tetrodotoxin | 4 | 2014 | 68 | 0.440 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 96 | 0.430 |
Why?
|
| Anticonvulsants | 3 | 2001 | 431 | 0.430 |
Why?
|
| Anesthetics, Local | 3 | 2004 | 163 | 0.430 |
Why?
|
| Sciatic Neuropathy | 2 | 2002 | 12 | 0.420 |
Why?
|
| Cerebellum | 1 | 2016 | 449 | 0.420 |
Why?
|
| Supraoptic Nucleus | 2 | 2001 | 8 | 0.420 |
Why?
|
| Oxotremorine | 9 | 2014 | 24 | 0.420 |
Why?
|
| Brain Injuries | 1 | 2018 | 787 | 0.420 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 4 | 2017 | 16 | 0.420 |
Why?
|
| Blotting, Western | 7 | 2016 | 3536 | 0.410 |
Why?
|
| Protein Binding | 7 | 2021 | 3438 | 0.410 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2012 | 67 | 0.400 |
Why?
|
| Lectins | 5 | 2010 | 151 | 0.400 |
Why?
|
| GABA Agonists | 5 | 2009 | 23 | 0.400 |
Why?
|
| Interneurons | 3 | 2007 | 144 | 0.390 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2004 | 110 | 0.390 |
Why?
|
| Calcium Channel Blockers | 5 | 2009 | 135 | 0.390 |
Why?
|
| Nitric Oxide Donors | 5 | 2007 | 51 | 0.390 |
Why?
|
| Oligopeptides | 4 | 2008 | 429 | 0.390 |
Why?
|
| Female | 43 | 2023 | 141928 | 0.390 |
Why?
|
| Baclofen | 5 | 2009 | 42 | 0.390 |
Why?
|
| Acetates | 3 | 2000 | 105 | 0.380 |
Why?
|
| Pirenzepine | 2 | 2016 | 9 | 0.380 |
Why?
|
| Repressor Proteins | 1 | 2018 | 1664 | 0.380 |
Why?
|
| Somatostatin | 3 | 2006 | 114 | 0.370 |
Why?
|
| RNA, Small Interfering | 4 | 2014 | 2216 | 0.370 |
Why?
|
| KATP Channels | 1 | 2010 | 12 | 0.370 |
Why?
|
| Naltrexone | 3 | 2008 | 87 | 0.370 |
Why?
|
| GTP-Binding Proteins | 4 | 2008 | 321 | 0.370 |
Why?
|
| Muscarinic Antagonists | 9 | 2006 | 83 | 0.370 |
Why?
|
| Glycine Agents | 2 | 2008 | 14 | 0.360 |
Why?
|
| Touch | 4 | 2017 | 71 | 0.360 |
Why?
|
| Yohimbine | 4 | 2023 | 26 | 0.360 |
Why?
|
| Stroke | 1 | 2018 | 1144 | 0.360 |
Why?
|
| Electroacupuncture | 5 | 2013 | 35 | 0.360 |
Why?
|
| Ion Channel Gating | 5 | 2011 | 141 | 0.350 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2020 | 47 | 0.350 |
Why?
|
| RNA, Messenger | 6 | 2023 | 6150 | 0.350 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 14289 | 0.350 |
Why?
|
| Aminobutyrates | 2 | 2008 | 16 | 0.340 |
Why?
|
| Cells, Cultured | 6 | 2020 | 5637 | 0.330 |
Why?
|
| Synaptophysin | 5 | 2007 | 79 | 0.330 |
Why?
|
| Neuroprotective Agents | 2 | 2018 | 215 | 0.320 |
Why?
|
| Histones | 3 | 2022 | 1466 | 0.320 |
Why?
|
| Digestive System | 3 | 1997 | 114 | 0.320 |
Why?
|
| Nitric Oxide Synthase Type I | 4 | 2017 | 53 | 0.320 |
Why?
|
| Cardiovascular Physiological Phenomena | 3 | 2001 | 44 | 0.310 |
Why?
|
| Reaction Time | 6 | 2006 | 234 | 0.310 |
Why?
|
| Inflammation | 6 | 2022 | 2522 | 0.310 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 3154 | 0.310 |
Why?
|
| Cyclic GMP | 3 | 2017 | 116 | 0.310 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 1491 | 0.300 |
Why?
|
| Tissue Culture Techniques | 2 | 2017 | 114 | 0.300 |
Why?
|
| Enzyme Inhibitors | 9 | 2008 | 1879 | 0.300 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2007 | 488 | 0.300 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 4053 | 0.290 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 669 | 0.290 |
Why?
|
| Benzodiazepines | 2 | 2011 | 170 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 3101 | 0.280 |
Why?
|
| Isoenzymes | 2 | 2017 | 614 | 0.280 |
Why?
|
| Receptors, GABA | 1 | 2005 | 17 | 0.270 |
Why?
|
| Receptors, Purinergic P1 | 3 | 2003 | 25 | 0.270 |
Why?
|
| Guanosine Diphosphate | 3 | 2010 | 27 | 0.270 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2003 | 122 | 0.260 |
Why?
|
| Thionucleotides | 3 | 2010 | 65 | 0.260 |
Why?
|
| Parasympathetic Nervous System | 1 | 2005 | 26 | 0.260 |
Why?
|
| Biophysics | 3 | 2010 | 111 | 0.260 |
Why?
|
| Periaqueductal Gray | 1 | 2004 | 13 | 0.250 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2004 | 9 | 0.250 |
Why?
|
| Calcium Channels, P-Type | 1 | 2004 | 10 | 0.250 |
Why?
|
| Egtazic Acid | 4 | 2010 | 54 | 0.250 |
Why?
|
| Nitric Oxide Synthase | 6 | 2003 | 314 | 0.250 |
Why?
|
| Angina Pectoris | 1 | 2004 | 80 | 0.250 |
Why?
|
| Analysis of Variance | 6 | 2014 | 2307 | 0.240 |
Why?
|
| Substantia Gelatinosa | 1 | 2004 | 3 | 0.240 |
Why?
|
| Miniature Postsynaptic Potentials | 2 | 2014 | 8 | 0.240 |
Why?
|
| Sodium Channels | 1 | 2004 | 109 | 0.240 |
Why?
|
| Phosphinic Acids | 3 | 2008 | 5 | 0.240 |
Why?
|
| S-Nitrosothiols | 2 | 2000 | 7 | 0.230 |
Why?
|
| Splanchnic Nerves | 3 | 2001 | 13 | 0.230 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2023 | 12 | 0.230 |
Why?
|
| Ethylmaleimide | 2 | 2017 | 14 | 0.230 |
Why?
|
| Abdomen | 5 | 1997 | 332 | 0.230 |
Why?
|
| Receptors, Glycine | 2 | 2014 | 22 | 0.230 |
Why?
|
| Receptors, Adrenergic | 1 | 2023 | 46 | 0.230 |
Why?
|
| Fentanyl | 2 | 2019 | 148 | 0.230 |
Why?
|
| Pericardium | 1 | 2004 | 157 | 0.230 |
Why?
|
| Aspartic Acid | 1 | 2023 | 126 | 0.230 |
Why?
|
| Chelating Agents | 3 | 2010 | 127 | 0.230 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 2 | 2014 | 12 | 0.220 |
Why?
|
| Gallbladder | 4 | 2001 | 69 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2010 | 1062 | 0.220 |
Why?
|
| Muscimol | 3 | 2008 | 13 | 0.220 |
Why?
|
| Histone Deacetylase 2 | 1 | 2022 | 35 | 0.220 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 2008 | 67 | 0.220 |
Why?
|
| Immunohistochemistry | 8 | 2006 | 7548 | 0.220 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 8 | 0.220 |
Why?
|
| Nucleus Accumbens | 1 | 2022 | 61 | 0.220 |
Why?
|
| Soluble Guanylyl Cyclase | 2 | 2017 | 15 | 0.220 |
Why?
|
| Spinothalamic Tracts | 1 | 2002 | 19 | 0.220 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 2009 | 38 | 0.220 |
Why?
|
| Atropine | 5 | 2005 | 52 | 0.220 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2002 | 15 | 0.220 |
Why?
|
| Ganglionectomy | 2 | 2012 | 4 | 0.210 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 4143 | 0.210 |
Why?
|
| Valine | 3 | 2014 | 176 | 0.210 |
Why?
|
| Cysteine | 2 | 2000 | 214 | 0.210 |
Why?
|
| Tritium | 3 | 2008 | 200 | 0.210 |
Why?
|
| Solitary Nucleus | 1 | 2001 | 8 | 0.210 |
Why?
|
| Organophosphorus Compounds | 1 | 2002 | 101 | 0.200 |
Why?
|
| Carbazoles | 2 | 2013 | 87 | 0.200 |
Why?
|
| Receptors, Bradykinin | 3 | 1998 | 4 | 0.200 |
Why?
|
| Blood Circulation | 1 | 2001 | 32 | 0.200 |
Why?
|
| Gene Products, tat | 1 | 2021 | 54 | 0.200 |
Why?
|
| Nerve Net | 1 | 2004 | 257 | 0.200 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2014 | 42 | 0.200 |
Why?
|
| Memantine | 2 | 2013 | 46 | 0.200 |
Why?
|
| Histone Code | 1 | 2022 | 79 | 0.200 |
Why?
|
| Cell Membrane Permeability | 1 | 2021 | 122 | 0.200 |
Why?
|
| KCNQ Potassium Channels | 2 | 2014 | 11 | 0.190 |
Why?
|
| Narcotic Antagonists | 3 | 2008 | 129 | 0.190 |
Why?
|
| Nestin | 1 | 2020 | 42 | 0.190 |
Why?
|
| Ligation | 4 | 2009 | 193 | 0.190 |
Why?
|
| Injections, Intravenous | 5 | 2005 | 573 | 0.190 |
Why?
|
| Skin | 3 | 2011 | 1259 | 0.190 |
Why?
|
| Ischemic Preconditioning | 1 | 2000 | 20 | 0.190 |
Why?
|
| Brain | 2 | 2023 | 4113 | 0.190 |
Why?
|
| Propionates | 1 | 2020 | 71 | 0.190 |
Why?
|
| Mercaptoethanol | 1 | 2000 | 17 | 0.180 |
Why?
|
| Nerve Tissue | 1 | 2020 | 10 | 0.180 |
Why?
|
| Heart Conduction System | 3 | 1996 | 165 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2013 | 1217 | 0.180 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 332 | 0.180 |
Why?
|
| Humans | 23 | 2022 | 261506 | 0.180 |
Why?
|
| Hypoxia | 2 | 2020 | 443 | 0.180 |
Why?
|
| Membrane Transport Proteins | 1 | 2001 | 244 | 0.180 |
Why?
|
| Cell Membrane | 2 | 2014 | 850 | 0.180 |
Why?
|
| Brain Stem | 3 | 2014 | 175 | 0.180 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 308 | 0.180 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 71 | 0.180 |
Why?
|
| Pyridazines | 2 | 2016 | 293 | 0.170 |
Why?
|
| Permeability | 1 | 2019 | 167 | 0.170 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 215 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2021 | 4804 | 0.170 |
Why?
|
| omega-Conotoxin GVIA | 2 | 2009 | 10 | 0.170 |
Why?
|
| Tetrazolium Salts | 1 | 2018 | 54 | 0.170 |
Why?
|
| Biophysical Phenomena | 2 | 2008 | 112 | 0.170 |
Why?
|
| Neuralgia, Postherpetic | 2 | 2021 | 8 | 0.170 |
Why?
|
| Propanolamines | 2 | 2008 | 44 | 0.170 |
Why?
|
| Flagella | 1 | 2018 | 39 | 0.170 |
Why?
|
| Microscopy, Confocal | 4 | 2010 | 663 | 0.170 |
Why?
|
| Versicans | 2 | 2008 | 28 | 0.160 |
Why?
|
| Alkenes | 2 | 2016 | 12 | 0.160 |
Why?
|
| Arginine | 2 | 2017 | 500 | 0.160 |
Why?
|
| Nicotinic Antagonists | 4 | 2001 | 17 | 0.160 |
Why?
|
| Chest Pain | 1 | 1999 | 155 | 0.160 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 2 | 2011 | 24 | 0.160 |
Why?
|
| Methylation | 1 | 2020 | 597 | 0.160 |
Why?
|
| Time Factors | 8 | 2013 | 12926 | 0.160 |
Why?
|
| Guanylate Cyclase | 2 | 2011 | 74 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 3639 | 0.160 |
Why?
|
| Benzoates | 2 | 2014 | 136 | 0.160 |
Why?
|
| Piperidines | 5 | 2016 | 1035 | 0.160 |
Why?
|
| Central Nervous System Agents | 1 | 2017 | 20 | 0.150 |
Why?
|
| Lysine | 1 | 2020 | 422 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 276 | 0.150 |
Why?
|
| Triazoles | 2 | 2014 | 617 | 0.150 |
Why?
|
| Bupivacaine | 1 | 1998 | 68 | 0.150 |
Why?
|
| Receptors, Ghrelin | 1 | 2017 | 35 | 0.150 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 47 | 0.150 |
Why?
|
| Naloxone | 2 | 2008 | 82 | 0.150 |
Why?
|
| Ghrelin | 1 | 2017 | 79 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 5539 | 0.140 |
Why?
|
| Xanthines | 2 | 2010 | 29 | 0.140 |
Why?
|
| Leukotriene B4 | 2 | 1995 | 20 | 0.140 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2016 | 11 | 0.140 |
Why?
|
| Protons | 1 | 1999 | 473 | 0.140 |
Why?
|
| Synaptosomes | 3 | 2000 | 37 | 0.140 |
Why?
|
| Kynurenic Acid | 2 | 2007 | 26 | 0.140 |
Why?
|
| Kidney | 4 | 2009 | 2146 | 0.140 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 726 | 0.140 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2016 | 87 | 0.130 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2008 | 726 | 0.130 |
Why?
|
| DNA | 1 | 2023 | 2693 | 0.130 |
Why?
|
| Infertility, Male | 1 | 2018 | 297 | 0.130 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 1995 | 30 | 0.130 |
Why?
|
| 2-Amino-5-phosphonovalerate | 2 | 2007 | 25 | 0.130 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 475 | 0.130 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 392 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2020 | 1442 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2008 | 747 | 0.120 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 65 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2015 | 611 | 0.120 |
Why?
|
| Glyburide | 2 | 2014 | 28 | 0.120 |
Why?
|
| Death, Sudden | 1 | 2014 | 59 | 0.120 |
Why?
|
| Sodium Channel Blockers | 2 | 2014 | 37 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 2021 | 1000 | 0.120 |
Why?
|
| Endosomes | 1 | 2014 | 109 | 0.120 |
Why?
|
| Glucose | 1 | 2020 | 1248 | 0.120 |
Why?
|
| Physical Exertion | 1 | 1993 | 113 | 0.110 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2004 | 38 | 0.110 |
Why?
|
| Hemodynamics | 4 | 2001 | 935 | 0.110 |
Why?
|
| Rotarod Performance Test | 1 | 2013 | 26 | 0.110 |
Why?
|
| Microtubules | 1 | 2014 | 270 | 0.110 |
Why?
|
| Cysteine Endopeptidases | 1 | 2014 | 251 | 0.110 |
Why?
|
| Mechanoreceptors | 2 | 2005 | 28 | 0.110 |
Why?
|
| Coronary Vessels | 5 | 2001 | 665 | 0.110 |
Why?
|
| Cyclopropanes | 1 | 2013 | 88 | 0.110 |
Why?
|
| Keratinocytes | 2 | 2011 | 241 | 0.110 |
Why?
|
| Peptide Fragments | 3 | 2006 | 1271 | 0.110 |
Why?
|
| Ganglia, Sympathetic | 1 | 2012 | 32 | 0.110 |
Why?
|
| Pyridines | 2 | 2014 | 1244 | 0.110 |
Why?
|
| Synaptic Potentials | 1 | 2012 | 16 | 0.110 |
Why?
|
| beta-Endorphin | 1 | 2011 | 42 | 0.100 |
Why?
|
| Mecamylamine | 2 | 2001 | 15 | 0.100 |
Why?
|
| Glycosylation | 1 | 2012 | 213 | 0.100 |
Why?
|
| Nitrosation | 1 | 2011 | 10 | 0.100 |
Why?
|
| Radioligand Assay | 2 | 2009 | 54 | 0.100 |
Why?
|
| Cannabidiol | 1 | 2012 | 42 | 0.100 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 311 | 0.100 |
Why?
|
| Injections, Intraventricular | 1 | 2011 | 114 | 0.100 |
Why?
|
| Temperature | 1 | 2013 | 506 | 0.100 |
Why?
|
| Intracellular Space | 2 | 2011 | 77 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 360 | 0.100 |
Why?
|
| Circadian Clocks | 1 | 2011 | 66 | 0.100 |
Why?
|
| Biological Transport | 1 | 2012 | 597 | 0.100 |
Why?
|
| Nickel | 2 | 2008 | 44 | 0.100 |
Why?
|
| Indole Alkaloids | 1 | 2010 | 7 | 0.100 |
Why?
|
| Nitroso Compounds | 2 | 2000 | 17 | 0.090 |
Why?
|
| Dizocilpine Maleate | 1 | 2010 | 21 | 0.090 |
Why?
|
| Receptor, trkB | 1 | 2010 | 53 | 0.090 |
Why?
|
| Tolbutamide | 1 | 2010 | 10 | 0.090 |
Why?
|
| Pertussis Toxin | 2 | 2007 | 57 | 0.090 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2010 | 6 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 216 | 0.090 |
Why?
|
| Deferoxamine | 3 | 2007 | 28 | 0.090 |
Why?
|
| Nodose Ganglion | 1 | 2009 | 6 | 0.090 |
Why?
|
| Phenotype | 1 | 2021 | 6295 | 0.090 |
Why?
|
| Chromones | 1 | 2009 | 120 | 0.090 |
Why?
|
| Arachidonic Acids | 1 | 2009 | 29 | 0.090 |
Why?
|
| Cell Line | 3 | 2012 | 5114 | 0.090 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2009 | 35 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2011 | 229 | 0.090 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2009 | 27 | 0.090 |
Why?
|
| Mibefradil | 1 | 2008 | 3 | 0.090 |
Why?
|
| Stimulation, Chemical | 2 | 2002 | 97 | 0.090 |
Why?
|
| Cyclopentanes | 1 | 2009 | 40 | 0.090 |
Why?
|
| Picrotoxin | 1 | 2008 | 18 | 0.090 |
Why?
|
| Dioxanes | 1 | 2008 | 11 | 0.090 |
Why?
|
| Strychnine | 1 | 2008 | 8 | 0.090 |
Why?
|
| Chitosan | 1 | 2009 | 79 | 0.090 |
Why?
|
| Triazines | 1 | 2010 | 117 | 0.090 |
Why?
|
| Amiloride | 1 | 2008 | 47 | 0.080 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 25 | 0.080 |
Why?
|
| Anthracenes | 1 | 2008 | 48 | 0.080 |
Why?
|
| Phenylephrine | 1 | 2008 | 48 | 0.080 |
Why?
|
| Rhizotomy | 1 | 2008 | 13 | 0.080 |
Why?
|
| Lactic Acid | 2 | 2002 | 305 | 0.080 |
Why?
|
| Indomethacin | 3 | 2000 | 91 | 0.080 |
Why?
|
| Pain Management | 2 | 2009 | 668 | 0.080 |
Why?
|
| Catecholamines | 1 | 1989 | 101 | 0.080 |
Why?
|
| Peripheral Nerves | 2 | 2000 | 159 | 0.080 |
Why?
|
| Cadmium | 1 | 2008 | 57 | 0.080 |
Why?
|
| Hypokalemia | 1 | 1989 | 55 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 693 | 0.080 |
Why?
|
| Vasoconstrictor Agents | 1 | 2009 | 151 | 0.080 |
Why?
|
| Seizures | 1 | 2014 | 989 | 0.080 |
Why?
|
| Myasthenia Gravis | 1 | 2009 | 99 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 202 | 0.080 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2008 | 27 | 0.080 |
Why?
|
| Splanchnic Circulation | 2 | 2001 | 53 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 4233 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 219 | 0.080 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2007 | 4 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2011 | 428 | 0.080 |
Why?
|
| Flavanones | 1 | 2007 | 11 | 0.080 |
Why?
|
| Thapsigargin | 1 | 2007 | 38 | 0.080 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2007 | 17 | 0.080 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2007 | 21 | 0.080 |
Why?
|
| Eating | 2 | 2017 | 421 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 189 | 0.080 |
Why?
|
| Myocardial Infarction | 3 | 1995 | 1374 | 0.080 |
Why?
|
| Metalloporphyrins | 1 | 2007 | 30 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 6089 | 0.070 |
Why?
|
| Extracellular Space | 1 | 2007 | 132 | 0.070 |
Why?
|
| Laminectomy | 1 | 2007 | 52 | 0.070 |
Why?
|
| Bradykinin Receptor Antagonists | 3 | 1998 | 3 | 0.070 |
Why?
|
| GABA Modulators | 1 | 2006 | 15 | 0.070 |
Why?
|
| Diazepam | 1 | 2006 | 39 | 0.070 |
Why?
|
| Cadmium Chloride | 1 | 2006 | 5 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2008 | 429 | 0.070 |
Why?
|
| Sulfur Radioisotopes | 2 | 2003 | 26 | 0.070 |
Why?
|
| Aryldialkylphosphatase | 1 | 2006 | 12 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 1756 | 0.070 |
Why?
|
| Sulfur Isotopes | 1 | 2006 | 3 | 0.070 |
Why?
|
| Benzylamines | 1 | 2006 | 105 | 0.070 |
Why?
|
| Glutamine | 1 | 2008 | 299 | 0.070 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 1 | 2006 | 7 | 0.070 |
Why?
|
| Myocardium | 3 | 2003 | 1313 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2014 | 1338 | 0.070 |
Why?
|
| Elapid Venoms | 1 | 2005 | 11 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2009 | 374 | 0.070 |
Why?
|
| Scorpion Venoms | 1 | 2005 | 15 | 0.070 |
Why?
|
| Adrenergic Antagonists | 1 | 2005 | 19 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2009 | 349 | 0.070 |
Why?
|
| Limbic System | 1 | 2005 | 29 | 0.070 |
Why?
|
| Microdialysis | 3 | 2000 | 50 | 0.070 |
Why?
|
| Portal Vein | 2 | 2001 | 355 | 0.070 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2005 | 28 | 0.070 |
Why?
|
| Imidazoles | 2 | 2003 | 999 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2007 | 148 | 0.070 |
Why?
|
| Tetraethylammonium | 1 | 2005 | 14 | 0.070 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2005 | 20 | 0.070 |
Why?
|
| Base Sequence | 1 | 2011 | 4917 | 0.060 |
Why?
|
| Ruthenium Red | 1 | 2004 | 6 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 482 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2005 | 257 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2015 | 2669 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2005 | 79 | 0.060 |
Why?
|
| Ferrets | 1 | 2004 | 25 | 0.060 |
Why?
|
| Protein Phosphatase 2 | 1 | 2005 | 88 | 0.060 |
Why?
|
| Hindlimb | 3 | 2009 | 105 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 136 | 0.060 |
Why?
|
| GABA-B Receptor Antagonists | 1 | 2004 | 2 | 0.060 |
Why?
|
| Disease Progression | 1 | 2015 | 6682 | 0.060 |
Why?
|
| Carbocyanines | 1 | 2004 | 41 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2004 | 37 | 0.060 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2004 | 30 | 0.060 |
Why?
|
| Pro-Opiomelanocortin | 2 | 2017 | 113 | 0.060 |
Why?
|
| Receptors, Angiotensin | 1 | 2003 | 44 | 0.060 |
Why?
|
| Losartan | 1 | 2003 | 46 | 0.060 |
Why?
|
| Neural Conduction | 3 | 2002 | 112 | 0.060 |
Why?
|
| omega-N-Methylarginine | 1 | 2003 | 34 | 0.060 |
Why?
|
| Autoradiography | 1 | 2002 | 132 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2004 | 190 | 0.060 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2003 | 46 | 0.050 |
Why?
|
| Reference Values | 3 | 2000 | 1099 | 0.050 |
Why?
|
| Young Adult | 1 | 2021 | 21445 | 0.050 |
Why?
|
| Prazosin | 1 | 2002 | 22 | 0.050 |
Why?
|
| Visceral Afferents | 1 | 2002 | 8 | 0.050 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2002 | 60 | 0.050 |
Why?
|
| Drinking | 1 | 2002 | 54 | 0.050 |
Why?
|
| Carboxypeptidases | 1 | 2002 | 27 | 0.050 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2002 | 15 | 0.050 |
Why?
|
| Tibial Nerve | 1 | 2002 | 18 | 0.050 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2002 | 31 | 0.050 |
Why?
|
| Dinoprostone | 2 | 2012 | 208 | 0.050 |
Why?
|
| Pregabalin | 1 | 2001 | 8 | 0.050 |
Why?
|
| Thiophenes | 1 | 2003 | 148 | 0.050 |
Why?
|
| Instillation, Drug | 1 | 2001 | 16 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2003 | 151 | 0.050 |
Why?
|
| Hemicholinium 3 | 1 | 2001 | 4 | 0.050 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 2001 | 4 | 0.050 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2001 | 6 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 2171 | 0.050 |
Why?
|
| Aziridines | 1 | 2001 | 17 | 0.050 |
Why?
|
| Neurons, Efferent | 1 | 2001 | 6 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 265 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2001 | 164 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2001 | 60 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 534 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 197 | 0.050 |
Why?
|
| Aspirin | 2 | 1995 | 455 | 0.050 |
Why?
|
| Celiac Artery | 1 | 2001 | 40 | 0.050 |
Why?
|
| Mesenteric Arteries | 1 | 2001 | 55 | 0.050 |
Why?
|
| Choline | 1 | 2001 | 76 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 600 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2576 | 0.050 |
Why?
|
| Vagotomy | 1 | 2000 | 26 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2021 | 66 | 0.050 |
Why?
|
| Stellate Ganglion | 1 | 2000 | 15 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2000 | 52 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2000 | 60 | 0.050 |
Why?
|
| Adolescent | 1 | 2021 | 31252 | 0.050 |
Why?
|
| Amino Acids, Cyclic | 1 | 2000 | 1 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2001 | 200 | 0.050 |
Why?
|
| Endocardium | 1 | 2000 | 50 | 0.050 |
Why?
|
| Lidocaine | 1 | 2000 | 76 | 0.050 |
Why?
|
| Nitrites | 1 | 2000 | 61 | 0.050 |
Why?
|
| Bile Ducts | 2 | 1997 | 113 | 0.040 |
Why?
|
| Kinetics | 1 | 2003 | 2049 | 0.040 |
Why?
|
| Buffers | 1 | 1999 | 44 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2000 | 67 | 0.040 |
Why?
|
| Hypercapnia | 1 | 1999 | 26 | 0.040 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 1999 | 32 | 0.040 |
Why?
|
| Electrodes | 1 | 1999 | 116 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 591 | 0.040 |
Why?
|
| Indans | 1 | 1999 | 68 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 1999 | 78 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2012 | 521 | 0.040 |
Why?
|
| Thalamus | 1 | 2000 | 132 | 0.040 |
Why?
|
| Perforant Pathway | 1 | 2018 | 15 | 0.040 |
Why?
|
| Anions | 1 | 2018 | 39 | 0.040 |
Why?
|
| Sympathectomy | 1 | 1998 | 14 | 0.040 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 8 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 1999 | 106 | 0.040 |
Why?
|
| Hydroxyl Radical | 2 | 1995 | 19 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 131 | 0.040 |
Why?
|
| Ion Transport | 1 | 2018 | 79 | 0.040 |
Why?
|
| Myocardial Reperfusion | 2 | 1995 | 108 | 0.040 |
Why?
|
| Alkaloids | 2 | 2010 | 75 | 0.040 |
Why?
|
| Median Nerve | 1 | 1998 | 24 | 0.040 |
Why?
|
| Blood Gas Analysis | 2 | 1999 | 100 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 2018 | 52 | 0.040 |
Why?
|
| Receptors, Histamine H1 | 1 | 1997 | 7 | 0.040 |
Why?
|
| Furans | 2 | 2010 | 104 | 0.040 |
Why?
|
| Gyrus Cinguli | 1 | 2000 | 140 | 0.040 |
Why?
|
| Histamine H1 Antagonists | 1 | 1997 | 25 | 0.040 |
Why?
|
| Naphthalenes | 2 | 2010 | 83 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 187 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2018 | 106 | 0.040 |
Why?
|
| Histamine | 1 | 1997 | 53 | 0.040 |
Why?
|
| Adult | 2 | 2021 | 77950 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 1995 | 217 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2000 | 483 | 0.040 |
Why?
|
| Agouti-Related Protein | 1 | 2017 | 51 | 0.040 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2017 | 50 | 0.040 |
Why?
|
| Software | 1 | 2004 | 1321 | 0.040 |
Why?
|
| Uterus | 1 | 2002 | 678 | 0.040 |
Why?
|
| Coronary Circulation | 2 | 1995 | 253 | 0.040 |
Why?
|
| China | 1 | 2018 | 606 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 3254 | 0.040 |
Why?
|
| Pancreas | 2 | 1997 | 718 | 0.040 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1996 | 9 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2000 | 1313 | 0.040 |
Why?
|
| Gastrointestinal Motility | 1 | 1997 | 92 | 0.040 |
Why?
|
| Spermatozoa | 1 | 2018 | 315 | 0.030 |
Why?
|
| Mesentery | 1 | 1996 | 72 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1998 | 621 | 0.030 |
Why?
|
| Naphthaleneacetic Acids | 1 | 1995 | 2 | 0.030 |
Why?
|
| Aminophylline | 1 | 1995 | 10 | 0.030 |
Why?
|
| Lipoxygenase | 1 | 1995 | 24 | 0.030 |
Why?
|
| Dipyridamole | 1 | 1995 | 33 | 0.030 |
Why?
|
| Neurokinin A | 1 | 1995 | 4 | 0.030 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 1995 | 17 | 0.030 |
Why?
|
| Captopril | 1 | 1994 | 34 | 0.030 |
Why?
|
| Complement C5a | 1 | 1995 | 36 | 0.030 |
Why?
|
| Substance P | 1 | 1995 | 71 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2000 | 610 | 0.030 |
Why?
|
| Lymph | 1 | 1994 | 76 | 0.030 |
Why?
|
| Pinacidil | 1 | 2014 | 2 | 0.030 |
Why?
|
| Membrane Transport Modulators | 1 | 2014 | 9 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 118 | 0.030 |
Why?
|
| 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 1 | 1993 | 1 | 0.030 |
Why?
|
| Testis | 1 | 2018 | 717 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2014 | 80 | 0.030 |
Why?
|
| Prostaglandin Antagonists | 1 | 1993 | 6 | 0.030 |
Why?
|
| Stiff-Person Syndrome | 1 | 2014 | 11 | 0.030 |
Why?
|
| Epoprostenol | 1 | 1994 | 75 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2013 | 63 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1995 | 197 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 591 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2001 | 2022 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 1993 | 218 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 2927 | 0.030 |
Why?
|
| Neutrophils | 2 | 1995 | 835 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2014 | 562 | 0.030 |
Why?
|
| Muscles | 1 | 1993 | 416 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 71 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 515 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2013 | 149 | 0.030 |
Why?
|
| Quinolines | 1 | 1995 | 383 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 3045 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 931 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 2010 | 12 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 634 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2011 | 358 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 750 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2014 | 898 | 0.020 |
Why?
|
| Idazoxan | 2 | 2000 | 4 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2009 | 43 | 0.020 |
Why?
|
| Endocannabinoids | 1 | 2009 | 21 | 0.020 |
Why?
|
| Sodium | 2 | 2000 | 353 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 1487 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2014 | 1145 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 6100 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1732 | 0.020 |
Why?
|
| Leucine | 2 | 2000 | 352 | 0.020 |
Why?
|
| Sheep | 2 | 1999 | 258 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 1993 | 987 | 0.020 |
Why?
|
| Epinephrine | 1 | 1989 | 255 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 548 | 0.020 |
Why?
|
| Potassium | 1 | 1989 | 329 | 0.020 |
Why?
|
| Rabbits | 1 | 1989 | 957 | 0.020 |
Why?
|
| Liver | 1 | 1997 | 2961 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 5047 | 0.020 |
Why?
|
| Regional Blood Flow | 2 | 1999 | 276 | 0.020 |
Why?
|
| Mutation | 2 | 2018 | 15179 | 0.020 |
Why?
|
| Thiourea | 2 | 1995 | 18 | 0.020 |
Why?
|
| Superoxides | 2 | 1995 | 211 | 0.010 |
Why?
|
| Peroxidase | 2 | 1995 | 132 | 0.010 |
Why?
|
| Macrophages | 1 | 2010 | 1304 | 0.010 |
Why?
|
| Carrageenan | 1 | 2003 | 15 | 0.010 |
Why?
|
| Indoles | 1 | 2009 | 1009 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1995 | 4367 | 0.010 |
Why?
|
| Dilatation | 1 | 2002 | 83 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 2001 | 18 | 0.010 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2001 | 22 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2002 | 156 | 0.010 |
Why?
|
| Electromyography | 1 | 2002 | 226 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2001 | 90 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2001 | 334 | 0.010 |
Why?
|
| Nomifensine | 1 | 2000 | 1 | 0.010 |
Why?
|
| omega-Conotoxins | 1 | 2000 | 7 | 0.010 |
Why?
|
| Desipramine | 1 | 2000 | 30 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 2000 | 55 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 2001 | 139 | 0.010 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2000 | 32 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2000 | 46 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2009 | 1471 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 300 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 2002 | 253 | 0.010 |
Why?
|
| Swine | 2 | 1995 | 1541 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 1382 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 160 | 0.010 |
Why?
|
| Feedback | 1 | 2000 | 198 | 0.010 |
Why?
|
| Sympatholytics | 1 | 1998 | 5 | 0.010 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 1998 | 16 | 0.010 |
Why?
|
| Nicotinic Agonists | 1 | 1999 | 113 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 14551 | 0.010 |
Why?
|
| Chlorpheniramine | 1 | 1997 | 1 | 0.010 |
Why?
|
| Dimaprit | 1 | 1997 | 1 | 0.010 |
Why?
|
| Methylhistamines | 1 | 1997 | 2 | 0.010 |
Why?
|
| Pyrilamine | 1 | 1997 | 2 | 0.010 |
Why?
|
| Adrenergic Agents | 1 | 1997 | 18 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1998 | 177 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 3869 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1998 | 160 | 0.010 |
Why?
|
| Duodenum | 1 | 1997 | 149 | 0.010 |
Why?
|
| Amino Acids | 1 | 2000 | 728 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1997 | 159 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1996 | 39 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 4757 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1995 | 80 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1995 | 61 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 2944 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 3472 | 0.010 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1994 | 10 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 157 | 0.010 |
Why?
|
| Diastole | 1 | 1995 | 187 | 0.010 |
Why?
|
| Sex Factors | 1 | 1999 | 2139 | 0.010 |
Why?
|
| Hydroxides | 1 | 1993 | 8 | 0.010 |
Why?
|
| Reperfusion | 1 | 1993 | 24 | 0.010 |
Why?
|
| Free Radicals | 1 | 1993 | 62 | 0.010 |
Why?
|
| Iron | 1 | 1995 | 376 | 0.010 |
Why?
|
| Oxygen | 1 | 1996 | 754 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1998 | 1863 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1995 | 603 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 3890 | 0.010 |
Why?
|
| Cell Movement | 1 | 1993 | 2466 | 0.000 |
Why?
|
| Aged | 1 | 1989 | 70117 | 0.000 |
Why?
|
| Middle Aged | 1 | 1989 | 86204 | 0.000 |
Why?
|